Senti Biosciences, Inc.

NASDAQ
SNTI
Stock
Yield per half year: +48.61%
Dividend yield: 0%
Sector: Healthcare

3.21 $

-0.1 $ -3.02%
0.237 $
10 $

Min/max per year

Share chart Senti Biosciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Senti Biosciences, Inc.

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.

more details
The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date
2022-06-09
ISIN
US81726A1007
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
link
All parameters

Grade

Underestimation
Title Value Grade
P/S 9.51 1
P/BV 0.3641 10
P/E 0 0
Efficiency
Title Value Grade
ROA -59.47 0
ROE -106.19 0
ROIC 0 0
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA -0.6122 10
Debt/Ratio 0.3152 10
Debt/Equity 0.7857 9
Growth impulse
Title Value Grade
Yield Revenue, % 2912.94 10
Yield Ebitda, % 186.62 10
Yield EPS, % 1244.77 10
More

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 3.31 $ 0 $ 0 $ -3.02 % 0 % 0 %
Week 3.05 $ 0 $ 0 $ 5.25 % 0 % 0 %
Month 3.17 $ 3.05 $ 3.32 $ 1.26 % 0 % 0 %
Three month 3.66 $ 2.88 $ 5 $ -12.3 % 0 % 0 %
Half a year 2.16 $ 2.86 $ 6.52 $ 48.61 % 0 % 0 %
Year 0.313 $ 0.237 $ 10 $ 925.56 % 0 % 0 %
3 years 9.94 $ 0.237 $ 10 $ -67.71 % 0 % 0 %
5 years 0 $ 0.237 $ 10.24 $ 0 % 0 % 0 %
10 years 0 $ 0.237 $ 10.24 $ 0 % 0 % 0 %
Year to date 4.17 $ 2.86 $ 5 $ -23.02 % 0 % 0 %

Main owners

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. Timothy K. Lu M.D., Ph.D. Co-Founder, CEO & Director 868.57k 1981 (44 years)
Dr. James J. Collins Ph.D. Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director 58.5k 1966 (59 years)
Dr. Kanya Rajangam M.D., Ph.D. President, Head of Research & Development and Chief Medical Officer 689.99k 1974 (51 year)
Dr. Wilson Wong Ph.D. Scientific Co-Founder & Member of Scientific Advisory Board N/A
Ms. Yvonne Li M.B.A. Interim CFO, Treasurer & Principal Accounting Officer 1960 (65 years)
Mr. Thomas P. Chung Vice President of Strategic Finance & Corporate Development
Ms. Dee Olomajeye Dragon Vice President of People Strategy & Culture

About company

Address: United States, South San Francisco. CA, 2 Corporate Drive - Open in google maps, Open in yandex maps
Website: https://www.sentibio.com